The International Conference on Genetics and Precision Medicine in Cardiology is held for the first time in Athens, at the Acropolis Museum, from 4 – 6 June, 2026, bringing together clinicians, researchers, policymakers, and stakeholders to explore how precision cardiology can move from scientific advancement to system-wide implementation, aligned with European priorities for health data, innovation, and resilience.
The Protonotarios Workshop on Treatable Inherited CV Diseases will be held as a pre-conference event, on June 4th, from 16:00 to 20:00 hrs. at Onassis Hospital, with Perry Elliott & Juan Kaski.
The Conference is organized by Onassis Hospital, in collaboration with the Greek Network on Precision Medicine in Cardiology and the International Cardiomyopathy Network (ICoN).
Cardiovascular disease remains the leading cause of mortality in Europe, demanding a shift toward more effective, sustainable, and equitable models of care. Clinical Genetics and Precision Medicine are redefining this landscape, enabling earlier diagnosis, more accurate risk stratification, and targeted interventions tailored to the individual patient. At the same time, they raise critical questions for health systems: how to integrate innovation into clinical pathways, ensure interoperability of data, build workforce capacity, and guarantee equitable access across populations.
At the intersection of science, policy, and society, this conference aims to ensure that innovation translates into equitable health outcomes.
Registration is required to secure your participation*. Register below free of charge.
*Registration for the Workshop on June 4th, is separate from the one for the Conference. Participation in person or on-line is offered.
Advancing Mechanism-Based Cardiovascular Care: Embedding genetics and molecular insights into clinical decision-making to improve diagnosis, prevention, and disease management at scale.
Redefining Disease through Data and Evidence: Leveraging registries, real-world data, and research infrastructures to better understand disease heterogeneity and inform policy and clinical guidelines.
Enabling Access to Innovation: Translating breakthroughs—such as gene therapies and precision interventions—into accessible, affordable, and sustainable care pathways.
Building Resilient and Equitable Health Systems: Aligning innovation with health system readiness, workforce skills, and governance frameworks to ensure no patient or population is left behind.
The Acropolis Museum
The Conference is held at the iconic new Acropolis Museum -opened in June 2009- situated on the south side of the Acropolis at a distance of 300 metres from its monuments.
